Position in VYGR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,379,692
-$882,388 QoQ
Shares Held
875,568
-19.3% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 5%
None 5%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. VYGR ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in VYGR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,379,692 | 875,568 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,262,080 | 1,084,499 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,992,337 | 1,283,156 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,419,874 | 1,421,182 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,057,437 | 1,496,284 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,828,085 | 1,380,615 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,464,505 | 1,105,044 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,436,206 | 813,680 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,292,716 | 1,105,555 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,868,029 | 932,231 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,036,784 | 778,940 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,817,372 | 333,395 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,772,119 | 229,847 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $858,947 | 140,811 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $556,616 | 94,023 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $652,617 | 110,426 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $238,201 | 31,260 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $84,714 | 31,260 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $121,045 | 46,025 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $216,081 | 52,320 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $286,655 | 60,861 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $342,570 | 47,912 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $492,644 | 46,171 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $582,678 | 46,171 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $399,406 | 43,651 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||